US 10738035
Hepatitis B antiviral agents
granted A61KA61K31/415A61K31/4155
Quick answer
US patent 10738035 (Hepatitis B antiviral agents) held by Enanta Pharmaceuticals, Inc. expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/415, A61K31/4155, A61K31/454, A61K31/4545